Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uncomplicated P. Falciparum Malaria in Children”

20 trials

Showing 20 of 20 results

Post-approval studies (Phase 4)Study completedNCT01017770
What this trial is testing

Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso

Who this might be right for
Uncomplicated P. Falciparum Malaria in Children
Centre Muraz 340
Post-approval studies (Phase 4)Study completedNCT00529867
What this trial is testing

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Who this might be right for
Malaria, Falciparum
Dafra Pharma 267
Testing effectiveness (Phase 2)Study completedNCT00243737
What this trial is testing

Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria

Who this might be right for
Malaria
Albert Schweitzer Hospital 70
Post-approval studies (Phase 4)Study completedNCT00119145
What this trial is testing

Kintampo Trial of Combination Therapy for Malaria

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 510
Post-approval studies (Phase 4)Study completedNCT01930331
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO

Who this might be right for
Plasmodium FalciparumMalaria, Falciparum
Ifakara Health Institute 60
Large-scale testing (Phase 3)Study completedNCT00386763
What this trial is testing

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Who this might be right for
MalariaFalciparum
Novartis 890
Testing effectiveness (Phase 2)Study completedNCT00331136
What this trial is testing

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 60
Large-scale testing (Phase 3)Study completedNCT01082705
What this trial is testing

Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children

Who this might be right for
P. Falciparum Malaria
Centers for Disease Control and Prevention 323
Large-scale testing (Phase 3)Study completedNCT00393679
What this trial is testing

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

Who this might be right for
FeverMalaria
Institute of Tropical Medicine, Belgium 4,112
Testing effectiveness (Phase 2)Study completedNCT01464138
What this trial is testing

Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children

Who this might be right for
Malaria
Jomaa Pharma GmbH 52
Large-scale testing (Phase 3)Study completedNCT05842954
What this trial is testing

Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 1,720
Large-scale testing (Phase 3)Study completedNCT00677833
What this trial is testing

Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa

Who this might be right for
Malaria, Falciparum
Pfizer 361
Post-approval studies (Phase 4)Study completedNCT01998295
What this trial is testing

Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine

Who this might be right for
Instantaneous Clearance
Muhimbili University of Health and Allied Sciences 45
Not applicableStudy completedNCT00461578
What this trial is testing

Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 800
Large-scale testing (Phase 3)Study completedNCT02083380
What this trial is testing

Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 448
Testing effectiveness (Phase 2)Ended earlyNCT00988507
What this trial is testing

Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Infection
Sanofi 440
Post-approval studies (Phase 4)Study completedNCT00808951
What this trial is testing

In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso

Who this might be right for
Malaria
Centre Muraz 440
Post-approval studies (Phase 4)Study completedNCT00425763
What this trial is testing

Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria

Who this might be right for
Malaria
Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Ended earlyNCT02497612
What this trial is testing

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Infection
Sanofi 377
Large-scale testing (Phase 3)Study completedNCT00709969
What this trial is testing

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Novartis 310
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation